NSEGeneral Updates28 Sept 2026 · 28 Sept 2026, 02:52 pm

General Updates

Wakefit Innovations Limited · WAKEFIT

✦ AI Summary

Wakefit Innovations Limited has informed the Exchange about the grant of 2,25,442 Employee Stock Options under the Wakefit Employee Stock Option Plan - 2019.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Wakefit Innovations Limited has informed the Exchange about Grant of Employee Stock Options under "Wakefit Employee Stock Option Plan - 2019"

Attachments (1)

📄

WAKEFIT2025_28092026145211_SE_Intimation_-_ESOP_Grant_September.pdf

pdf

Download →
View document text
Date: September 28, 2026 BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Mumbai- 400001, Bandra Kurla Complex, Bandra (E), Maharashtra, India Mumbai – 400 051 BSE Scrip Code: 544642 NSE Scrip Symbol: WAKEFIT Subject: Grant of Employee Stock Options under “Wakefit Employee Stock Option Plan - 2019 [ESOP 2019]” (“WAKEFIT ESOP-2019” / “Plan”) Dear Sir/ Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform that the Nomination and Remuneration Committee (“NRC”) of the Board of Directors of the Company vide resolution passed on September 28, 2026, has approved, the grant of 2,25,442 (Two Lakh Twenty Five Thousand Four Hundred and Forty Two) Employee Stock Options (“Options”) under the WAKEFIT ESOP-2019. The grant of the above stock options is in line with the provisions of the SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021 as amended from time to time. The details required pursuant to Regulation 30 of the Listing Regulations read with SEBI circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“Master Circular”) are enclosed hereto as Annexure - A. The aforesaid information shall be made available on the Company's website at: www.wakefit.co/investor-relations You are requested to kindly take the same on record. Thanking you. Yours faithfully, For Wakefit Innovations Limited (formerly known as Wakefit Innovations Private Limited) Surbhi Sharma Company Secretary and Compliance Officer Membership Number: A57349 Annexure – A The details required pursuant to Regulation 30 of the Listing Regulations read with SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Sr. Particulars Details 1 Brief details of options granted; 2,25,442 (Two Lakh Twenty Five Thousand Four Hundred and Forty Two) Employee Stock Options (“Options”) have been granted by the Nomination and Remuneration Committee (“NRC”) in terms of the WAKEFIT ESOP-2019 2 Whether the scheme is in terms of Yes SEBI (SBEB) Regulations, 2021 (if applicable); 3 Total number of shares covered by these 2,25,442 (Two Lakh Twenty Five Thousand Four options; Hundred and Forty Two) Options exercisable into not more than 2,25,442 (Two Lakh Twenty Five Thousand Four Hundred and Forty Two) equity shares of face value of Re. 1/- (Rupee One Only). 4 Pricing formula The exercise price determined is Re. 1/- per Option. 5 Options vested Not Applicable 6 Time within which option may be All vested Options shall be exercisable within a exercised maximum period of 1 (One) year from the date of vesting of the respective Options. 7 Options exercised 8 Money realized by exercise of options 9 The total number of shares arising as a Not Applicable, as the present disclosure is related to result of exercise of option grant of stock options. 10 Options lapsed 11 Variation of terms of options 12 Brief details of significant terms Options will vest after a minimum period of 12 months from the Grant Date and not later than 5 years. Vesting will be as per the Letter of Grant, based on time and/or performance criteria, and subject to continued employment. Vesting timelines may be extended for unauthorized or non-statutory leaves as per the ESOP Plan. All other significant terms are governed by the ESOP Plan of the Company. 13 Subsequent changes or cancellation Not Applicable, as the present disclosure is related to or exercise of such options grant of stock options. 14 Diluted earnings per share pursuant to Not Applicable, as the present disclosure is related to issue of equity shares on exercise of grant of stock options. options.